Skip to main content

Advertisement

Figure 5 | Molecular Cancer

Figure 5

From: Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells

Figure 5

Effects of Bortezomib in Nthy-ori 3–1 cells ectopically expressing AGR2. A) Nthy-ori 3–1 cells transfected with AGR2, AGR2 (C → S) or with the empty vector (pcDNA) were treated for 24 hours with Bortezomib 100 nM. After treatment, cells were collected by trypsinization and counted in triplicate. The percentage of total cell number respect to untreated cells is reported ± standard deviations. B) Nthy-ori 3–1 cells transfected with AGR2, AGR2 (C → S) or with the empty vector (pcDNA) were treated for 24 hours with Bortezomib 100 nM. After treatment, cells were lysed, and protein lysates were subjected to immunoblotting with the indicated antibodies. Asterisks indicate P < 0.001 (***).

Back to article page